Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Veracyte Inc shares valued at $234,630 were sold by Leite John on Mar 07 ’25. At $31.66 per share, Leite John sold 7,411 shares. The insider’s holdings dropped to 100,249 shares worth approximately $3.02 million following the completion of this transaction.
Also, JOHN LEITE purchased 7,411 shares, netting a total of over 240,932 in proceeds.
Before that, ANN MCGUIRE had added 1,142 shares to its account. In a trade valued at $38,326, the Officer bought Veracyte Inc shares for $33.56 each.
As published in their initiating research note from Craig Hallum on March 20, 2025, Veracyte Inc [VCYT] has been a Buy and the price target has been revised to $45. Analysts at Goldman downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early December. As of November 15, 2024, Wolfe Research has initiated its “an Outperform” rating for VCYT. Earlier on October 16, 2024, UBS initiated its rating. Their recommendation was “a Buy” for VCYT stock.
Analyzing VCYT Stock Performance
During the last five days, there has been a drop of approximately -2.96%. Over the course of the year, Veracyte Inc shares have dropped approximately -23.91%. Shares of the company reached a 52-week high of $47.32 on 01/30/25 and a 52-week low of $28.52 on 03/31/25. A 50-day SMA is recorded $36.85, while a 200-day SMA reached $33.95.
Support And Resistance Levels for Veracyte Inc (VCYT)
According to the 24-hour chart, there is a support level at 28.90, which, if violated, would cause prices to drop to 27.67. In the upper region, resistance lies at 31.11. The next price resistance is at 32.10. RSI (Relative Strength Index) is 37.06 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.50, which suggests the price will decrease in the coming days. Percent R is at 71.60%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.